Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
20-23 October, 2025
62nd Japanese Peptide62nd Japanese Peptide
Not Confirmed
Not Confirmed
21-23 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
20-23 October, 2025
62nd Japanese Peptide62nd Japanese Peptide
Industry Trade Show
Not Confirmed
21-23 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india
02 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/02/3091683/0/en/Liquidia-Schedules-First-Commercial-Shipment-of-YUTREPIA-treprostinil-Inhalation-Powder-for-Patients-with-PAH-and-PH-ILD.html
28 May 2025
// PRESS RELEASE
https://liquidia.com/news-releases/news-release-details/liquidia-corporation-present-2025-jefferies-global-healthcare
23 May 2025
// PRESS RELEASE
https://www.liquidia.com/news-releases/news-release-details/us-fda-approves-liquidias-yutrepiatm-treprostinil-inhalation
12 May 2025
// PRESS RELEASE
https://liquidia.com/news-releases/news-release-details/liquidia-corporation-provides-update-litigation-filed-united
08 May 2025
// PRESS RELEASE
https://liquidia.com/news-releases/news-release-details/liquidia-corporation-reports-first-quarter-2025-financial
16 Sep 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/sandoz-wins-137m-damages-after-prevailing-years-long-generic-remodulin-dispute-united
ABOUT THIS PAGE
Liquidia Corporation is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of MOLD TEMPLATE FORMULATION 1 FOR PRINT® PROCESS bulk with DMF offered by Liquidia Corporation